NMD4C Members Presenting at Cure SMA Canada’s Winter Conference
About this Event, hosted by Cure SMA Canada
Thursday December 10 – Sunday December 13, 2020
Welcome to the Cure SMA Canada national SMA conference!
Cure SMA Canada are excited to be able to provide engaging, diverse, and informative topics for Canada’s SMA community to learn, heal and grow. Together we create an amazing cohesive community, learning from each other and making every tomorrow better than today.
Cure SMA would like to thank their sponsors, presenters and attendees.
NMD4C Presenters:
The NMD4C is excited to see many of its members present at this conference!
- Mise à jour sur le Risdiplam. Dr. Maryam Oskoui
- Nusinersen treatment update for adults with SMA. Dr. Erin K. O’Ferrall
- Care for the Caregiver. Rhonda Teichrob
- Spinraza – mise à jour pédiatrique. Dr. Nicolas Chrestian
- Pediatric update on Spinraza. Dr. Hernan Gonorazky
- Risdiplam update. Dr. Maryam Oskoui
- Peripheral pathology in SMA: Implications for clinical care (What goes wrong in SMA and how to fix it – lessons learned from recent studies). Dr. Rashmi Kothary
- Biomarkers for SMA. Dr. Robin Parks
- À la recherche du role d’SMN dans les neurones et muscles : une stratégie pour l’identification de nouvelles cibles thérapeutiques pour l’Amyotrophie Spinale Infantile. Dr. Jocelyn Côté
- Teens/adult transition and the importance of multidisciplinary care. Dr. Aaron Izenberg
- The Changing Landscape of Respiratory Care for SMA. Dr. Reshma Amin
Click Here for the full Agenda
Register Now!
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.